Taysha Gene Therapies, Inc. TSHA Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s free cash flow margin?
- Taysha Gene Therapies, Inc. (TSHA) reported free cash flow margin of -1,503.6% in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s free cash flow margin changed year-over-year?
- Taysha Gene Therapies, Inc.'s free cash flow margin decreased by 29.2% year-over-year, from -1,163.6% to -1,503.6%.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s free cash flow margin?
- Over 2 years (2023 to 2025), Taysha Gene Therapies, Inc.'s free cash flow margin has grown at a 38.9% compound annual growth rate (CAGR), from -497.6% to -960.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.